Aziyo Biologics Inc (AZYO)
NASDAQ
News
Market Data
Register for real-time alerts, custom portfolio, and market movers
The current AZYO market cap is 28.09M. The company's latest EPS is USD -1.9973 and P/E is -0.75.
| Quarter End | Jun 2023 | Sep 2023 | Dec 2023 | Mar 2024 | Jun 2024 |
|---|---|---|---|---|---|
| USD ($) | USD ($) | USD ($) | USD ($) | USD ($) | |
| Total Revenue | 10.3M | -4.48M | 5.88M | 6.69M | 6.29M |
| Operating Income | -9.09M | -6.52M | -8.51M | -8.48M | -8.51M |
| Net Income | -10.62M | -9.75M | -9.31M | -17.99M | -28.18M |
| Year End December 30 2023 | 2019 | 2020 | 2021 | 2022 | 2023 |
|---|---|---|---|---|---|
| USD ($) | USD ($) | USD ($) | USD ($) | USD ($) | |
| Total Revenue | 42.9M | 42.68M | 47.39M | 49.19M | 24.75M |
| Operating Income | -8.41M | -13.6M | -23.03M | -31.74M | -30.53M |
| Net Income | -11.94M | -25.34M | -24.83M | -32.9M | -37.66M |
| Quarter End | Jun 2023 | Sep 2023 | Dec 2023 | Mar 2024 | Jun 2024 |
|---|---|---|---|---|---|
| USD ($) | USD ($) | USD ($) | USD ($) | USD ($) | |
| Total Assets | 52.33M | 54.58M | 43.43M | 35.36M | 41.9M |
| Total Liabilities | 74.46M | 84.05M | 82.03M | 85.66M | 106.24M |
| Total Equity | -22.13M | -29.47M | -38.6M | -50.3M | -64.34M |
| Year End December 30 2023 | 2019 | 2020 | 2021 | 2022 | 2023 |
|---|---|---|---|---|---|
| USD ($) | USD ($) | USD ($) | USD ($) | USD ($) | |
| Total Assets | 44.77M | 82.81M | 67.17M | 68.84M | 43.43M |
| Total Liabilities | 55.43M | 61.98M | 53.65M | 73.87M | 82.03M |
| Total Equity | -55.11M | 20.83M | 13.52M | -5.03M | -38.6M |
| Quarter End | Jun 2023 | Sep 2023 | Dec 2023 | Mar 2024 | Jun 2024 |
|---|---|---|---|---|---|
| USD ($) | USD ($) | USD ($) | USD ($) | USD ($) | |
| Operating | -7.56M | -12.68M | -21.76M | -2.64M | -6.97M |
| Investing | -267k | -329k | 14.21M | -15k | 167k |
| Financing | 129k | 10.54M | 9.84M | -4.07M | 5.72M |
| Year End December 30 2023 | 2019 | 2020 | 2021 | 2022 | 2023 |
|---|---|---|---|---|---|
| USD ($) | USD ($) | USD ($) | USD ($) | USD ($) | |
| Operating | -7.23M | -13.63M | -15.45M | -21.43M | -21.76M |
| Investing | -577k | -640k | -369k | -540k | 14.21M |
| Financing | 7.98M | 51.21M | 6.71M | 8.54M | 9.84M |
| Market Cap | 28.09M |
| Price to Earnings Ratio | -0.75 |
| Price to Sales Ratio | 1.14 |
| Price to Cash Ratio | 1.46 |
| Price to Book Ratio | -0.73 |
| Dividend Yield | - |
| Shares Outstanding | 18.85M |
| Average Volume (1 week) | 0 |
| Average Volume (1 Month) | 0 |
| 52 Week Change | - |
| 52 Week High | - |
| 52 Week Low | - |
| Spread (Intraday) | 0.04 (2.61%) |
| Company Name | Aziyo Biologics Inc |
| Address |
251 little falls drive wilmington, delaware 19808 |
| Website | https://www.elutia.com |
| Industry | biological pds,ex diagnstics (2836) |
It looks like you are not logged in. Click the button below to log in and keep track of your recent history.
